Growth Strategy I

in collaboration with

ceo breakfast series on growth strategies for small to mid-cap ($10-$100MM)  companies in the MedTech industry


Wednesday, 14 January 2015

7:30am—9:30am | Constant Contact | 1601 Trapelo Road | Waltham

by personal invitation only | registration


Gordon Craig, CEO of Sterngold Dental LLC

which is the union of two strong companies with impressive dental histories: APM-Sterngold and ImplaMed. Sterngold was founded in 1897 as a fabricator of precious alloys, and is credited as among the first to produce consistently formulated and alloyed dental casting golds.

Jeffrey Thumm, CEO of Albright Technologies

which is your fastest source for long and short term implantable medical silicone molded parts. We specialize in manufacturing prototype and low volume production silicone components with a specific focus on quality, delivery, and innovation. With our extensive silicone molding experience we can help you with medical silicone material selection and design for manufacturability.

Discussion Leaders:

Dick O’Brien, Past President MDG, Principal, Nagog Hill Partners

Rudi Scheiber-Kurtz, CEO, Next Stage Sol

Bob Weber, Managing Director, Next Stage Solutions

Who should Attend: CEOs, Business Owners, CFOs, COOs and Board Members

In this first of a 3-part Breakfast Series we will be addressing challenges and opportunities of mid-market MedTech companies to achieve profit-able growth.

The discussions will include how and why to make an acquisition or enter a partnership agreement. The topic will be approached from different points of view provided by the experts and will look at the “Business of doing Business”. This holistic approach will include the Technical as well as the Human Capital side in the dialogue.

Growth Strategy  II | Product & Market Diversification | April 16

Growth Strategy III | Scalability Issues | June 10

For more information: Bob Weber 617-449-7728 | Next Stage Solutions, Inc

67 South Bedford Street, Suite 400 West, Burlington, MA 01803

NEXT STAGE SOLUTIONS, INC. | 617- 449-7728

Developing Medical Devices For Children: Opportunities & Challenges

MDG October 2013 Forum:

Developing Medical Devices For Children: Opportunities & Challenges

This program will be at Children’s Hospital, Boston. Cutoff for preregistration is 6 p.m. Oct. 7


The development of medical devices for children has greatly lagged behind the development of devices for adults. The label “child” covers such diverse periods of human growth — from newborn to age 17 — that it creates a segmented and tiny market for device makers. Technical barriers challenge engineers to develop products for rapidly changing bodies. Implanted rigid devices do not grow with the child. And unless devices are designed with exquisite consciousness of child behavior, safety and patient compliance may be extremely difficult to attain.

Despite these challenges, some companies have succeeded in small, niche markets. There also are opportunities for incredible engineering accomplishments in solving health care needs. While the FDA has set up incentives for developing child age-specific pharmaceuticals, there is no similar program for medical devices.

Our October program will feature a panel of experts discussing the economic gaps, will examine some of the unique engineering hurdles and will look at one model for addressing some of these challenges.


  • Don Lombardi, CEO, Institute for Pediatric Innovation
  • Aaron Sandoski, Managing Director, Norwich Ventures
  • George Kenney, President, EntraTympanic
Lombardi Lombardi Lombardi
Lombardi Sandoski Kenney

Who Should Attend:

  • Entrepreneurs with a commitment to improving the lives of sick children
  • Engineers ready for a challenge to current ways of conceiving and designing products
  • Small and medium size medical device product development teams eager to cultivate new ground in the industry
  • Parents seeking answers to the heretofore insoluble problems of getting therapies that work for young bodies and minds
  • Clinicians hungry for alternatives to jerry-rigging oversize adult devices for small children
  • Anyone with an interest in how life sciences can effectively turn its attention to creating to previously intractable problems in serving some of the most vulnerable among us

About MDG

The Medical Development Group (MDG) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care. MDG pursues this mission through the organization of educational programs and forums: the facilitation of cross-disciplinary dialogue and collaboration; the creation of venues for networking and information sharing for current and aspiring professionals, clinicians, and entrepreneurs; and the development of alliances with complementary organizations.